
Amerisleep Organica Mattress Review 2025: Versatile and Certified Organic Comfort
With 5+ years of mattress testing experience, we use our different sleeping position and body type perspectives to offer well-rounded, honest reviews.
8.0 /10
SCORE
CNET Score
With five-plus years of mattress testing experience, we use our different sleeping position and body type perspectives to offer well-rounded, honest reviews.
Read more on How we test
Our Verdict
Our Verdict
Best for:
Back sleeper
Stomach sleeper
Score Breakdown
Performance
8 /10
Policies
7.5 /10
Durability
8.5 /10
Features
8 /10
Pros and Cons
Pros
Two different models
For side sleepers
Responsive latex feel
Organic materials
Cons
Not everyone loves latex
Not good for light sleepers
Amerisleep Organica
8.0/10 CNET Score
$1,749 $1,299 at Amerisleep
Amerisleep is best known for its memory foam beds and the newly released AS6 Black Series mattress. The Organica line is the brand's latex offering. Latex foam mattresses are known for being more 'natural' than other types of beds and are popular among eco-conscious shoppers.
The two Organica mattresses will satisfy shoppers looking for a natural and organic mattress and provide a specific type of comfort and options that should suit your firmness preference.
First impressions of the Amerisleep Organica mattress
Jon Gomez/CNET
The team unboxed the original Organica mattress quite a while ago, and to be honest, the mattress got a bit lost in the shuffle. The nature of latex foam beds like Organica means that it has a lot of similarities in design, firmness and feel to other beds in its class, like the Avocado Green, the Awara Natural and the Winkbed EcoCloud. It is just difficult to stand out when the competition is using the same specific materials.
When the new Amerisleep Organica Plush first arrived, I was immediately surprised by just how plush it was. Most beds right out of the box are a bit soft -- but even after a few days, the Organica Plush was easily the softest latex hybrid bed I've tested.
Dillon Payne/CNET
This is great news because not many beds in this category are plush, and Organica can now fill that niche.
Is the Amerisleep Organica mattress right for you?
The Organica mattress is a solid pick for anyone looking for a latex foam hybrid mattress with organic certifications. It's relatively affordable compared to the competition, and the new Organica Plush model for side sleepers is a fantastic choice for side sleepers who want something soft and organic.
Amerisleep Organica mattress firmness and feel
Organica mattress feel
The feel of both versions of the Organica mattress is virtually identical. It's similar to most beds with latex foam in their construction.
Latex foam is a naturally bouncy material. When you press down on it with your hand and then take your hand away, it snaps back into shape almost immediately, so it's responsive and moves with you.
Dillon Payne/CNET
If you've ever tried a memory foam bed, latex foam is basically the exact opposite. When rotating between sleeping positions, like from your side to your back, it feels like the material is almost propelling you, which is jarring if you've tried a latex bed before. I personally find latex foam beds comfortable (although I'm sleeping on a memory foam bed right now), but not everyone does.
We cycle through beds at our office a lot when new models come out, and old ones are no longer available. I have noticed that when people come to our office to test out beds, latex foam ones seem to be liked the least. That is obviously anecdotal, and lots of people enjoy the feel of latex foam but just know it's unlike most traditional beds.
Organica firmness
The Organica mattress is now available in two different models, with the key difference being the firmness profile. The base model Organica is between a medium and a medium-firm on our firmness scale (roughly a 6.5 out of 10). This means it should work well for all sleeper types: back, stomach, side and combination. Combination sleepers who spend part of the night in one position and then switch are usually fans of this type of firmness profile, as are couples.
JD Christison/CNET
Side sleepers generally favor beds with a softer profile that cradles their hips and shoulders and offers pressure relief. The newer Organica Plush fits that bill, and our Mattress Smasher 9000 rated it 2.5 out of 10. It is easily the softest latex mattress we've tested to date.
Dillon Payne/CNET
This is great news for side sleepers looking for an organic latex mattress because the second softest latex bed we've tested to date is the Winkbed Ecocloud (5.1 out of 10).
Amerisleep Organica mattress construction
The construction of both models of Organica is pretty standard for a latex foam hybrid.
The main support layer of Organica is an 8-inch layer of individually wrapped, responsive coils. This provides plenty of support for every body type, including heavier folks.
Above the coil layer is a 1-inch layer of natural Talalay latex foam. This layer of latex foam is a bit firmer and functions as a buffer between the comfort foam above and the coil layer below.
The main comfort layer is a 2-inch layer of soft Talalay latex foam. Between the latex foam and the organic cotton cover is a 1-inch layer of organic wool for more padding and a fire barrier.
Jon Gomez/CNET
On the Organica Plush, an additional 3 inches of latex foam softens the bed significantly. This bed has a whopping 6 inches of latex foam in the mattress.
Organica certifications
As I've mentioned a few times, pretty much every material used in constructing the Organica mattress has some certification to show that it is organic and eco-friendly.
The latex foam has GOLS (Global Organic Latex Standard) and Oeko-Tex Standard 100 certifications. The wool and cotton are GOTS (Global Organic Textile Standard) certified.
The Organica mattress is a great choice if you're looking for an eco-friendly mattress.
Earthfoam mattress performance
Edge support
The edge support of a mattress is important for couples sharing a mattress. If the bed's perimeter doesn't hold up well under pressure, it can lead to poor sleep due to feeling like you're going to roll off the bed.
Jon Gomez/CNET
The edge support for both versions of Organica is good. You will feel more supported by the base model than the Plush model because it is firmer and there's less material between you and the support coils, but I don't see people having issues on either one.
The coils along the perimeter of the bed are made with a thicker gauge of steel, which provides improved edge support and is helpful for couples.
Motion Isolation
Motion isolation is another factor important for couples because a bed with poor motion isolation can wake you up if your partner tosses and turns throughout the night.
This is an area where the Organica mattress doesn't perform that well because of the nature of latex foam. It's so bouncy and responsive that if your partner tosses and turns at night, you will likely feel like and if you're a light sleeper, that can lead to disrupted sleep.
If you're a heavy sleeper who doesn't even wake up easily, then this won't be an issue, but light sleepers might have problems with Organica.
Temperature regulation
I'd describe the Organica mattress as sleeping temperature neutral. Latex foam is naturally breathable, and the molds mattress makers use to manufacture latex foam create perforations in the foam that improve airflow even more.
Dillon Payne/CNET
Organic beds made with wool can sleep warmer than average, as two members of our teams discovered when they sleept on the Avocado Luxury Organic mattress for a full month. Sleeping hot has way more to do with your sleeping environment than your specific mattress, so I wouldn't worry too much.
Organica (base model) mattress pricing
Size Measurements (inches) Price Twin 38x75 $1,499 Twin XL 38x80 $1,549 Full 54x75 $1,699 Queen 60x80 $1,749 King 76x80 $2,049 Cal king 72x84 $2,049
The base model Organica mattress is competitively priced when compared to other latex foam hybrids. It's more affordable than the base model Avocado Green mattress, the Winkbed EcoCloud and the Birch Natural. It's also usually discounted heavily to bring the retail price down.
The Organica Plush is expensive, though. A queen-size Organica Plush costs an additional $1,250 on top of the retail price of the base model, coming out to $2,999. This price puts it in the luxury tier.
Dillon Payne/CNET
Amerisleep mattress policies
Free shipping
Like most online mattresses, the Organica will ship right to your door at no extra cost inside a large box (as long as you live in the contiguous United States). If you live outside the US or in Alaska or Hawaii, you must pay for a 'freight forwarder' to get this bed shipped to you.
Unboxing this particular mattress isn't easy because it's quite heavy, so you should definitely have a friend there to help you remove it from the box.
100-night trial
Amerisleep provides a standard 100-night in-home sleep trial with all of its beds. Keep in mind that your sleep trial begins the day you receive the mattress so make sure you get it unboxed as quickly as you can and start sleeping on it because it can take up to 30 nights for your body to adjust to a new bed.
Return policy
Within the 100-night trial period, but not before night 30, you can return the Organica and get a full refund with no additional cost, making the mattress a risk-free purchase.
Like most brands, Amerisleep will ask you to sleep on the bed for at least 30 nights before initiating a return because no matter how nice and well-suited your new mattress is to your sleep type, your body needs a bit of time to adjust to it.
Warranty
The Organica mattresses are backed by a 20-year warranty, double the length of the standard 10-year warranty. This covers manufacturer defects, and if your mattress develops sagging beyond normal wear and tear, you should be covered.
How does the Organica mattress compare to similar mattresses?
Organica vs. WinkBed EcoCloud
The WinkBed EcoCloud is another latex foam hybrid with several organic certifications. Before we tested the Organica Plush, the WinkBed EcoCloud was the softest latex hybrid bed, rating a true medium on our firmness scale. It strikes a nice balance between comfort and support and has the same type of ultrabouncy feel. It's much more affordable than the Organica Plush but a bit more expensive than the base model Organica.
Organica vs. Avocado Green
The Avocado Green mattress is the industry leader for latex beds and features an impressive number of certifications for its materials and production processes. Avocado is also available in different options: base, pillow-top and box pillow-top models. The box pillow-top model is most similar to the Organica Plush as it's soft and designed for side sleepers.
Final thoughts on the Organica mattress
The base model Organica doesn't stand out from the latex foam hybrid crowd in a significant way, but it is a solid all-around choice. It has all the certifications eco-conscious shoppers are looking for: a relatively accommodating firmness profile, the standard latex foam feel, and it's not too expensive.
Final thoughts on the Organica mattress
The base model Organica doesn't stand out from the latex foam hybrid crowd in a significant way, but it is a solid all-around choice. It has all the certifications eco-conscious shoppers are looking for: a relatively accommodating firmness profile, the standard latex foam feel, and it's not too expensive.
Dillon Payne/CNET
But with the addition of the Organica Plush option and being so soft -- this is the best option for side sleepers looking for a latex bed. Most latex foam beds are on the firmer end of the spectrum and this is easily the softest latex beds we've tested. So, for side sleepers who want an organic mattress, the Organica Plush is a great decision if it fits your budget.
You might like the Organica mattress if:
You want a bouncy feel
You enjoy a firm mattress
You want an organic mattress
You want a soft mattress
You might not like the Organica mattress if:
You prefer the feel of memory foam
You're shopping on a budget
You want especially firm mattresses
Other mattresses from Amerisleep
Amerisleep AS3: This is Amerisleep's most popular mattress, sitting right in the middle of its AS1-5 lineup in terms of firmness. It should work fairly well for all sleeping positions. It is available in a coil model and a foam model. It now has a cooling cover added at no extra cost. This bed is made with Amerisleep's 'BioPur' memory foam in its main comfort layer, which has virtually the exact opposite type of feel when compared to Organica.
Amerisleep AS6 Black Series: This is Amerisleep's newest bed and one of the most luxurious memory foam beds we've tested. It's packed full of features like an active cooling cover, zoned support and edge support coils, and it comes in three different firmness profiles. It's roughly the same price as the Organica Plush, but thanks to its body-conforming memory foam, it has the exact opposite type of feel.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution
In the last year, many Cardinal Health, Inc. (NYSE:CAH) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The CEO & Director, Jason Hollar, made the biggest insider sale in the last 12 months. That single transaction was for US$8.0m worth of shares at a price of US$109 each. That means that an insider was selling shares at slightly below the current price (US$161). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 46% of Jason Hollar's holding. Cardinal Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! View our latest analysis for Cardinal Health I will like Cardinal Health better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying. Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Cardinal Health insiders own about US$146m worth of shares (which is 0.4% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders. The fact that there have been no Cardinal Health insider transactions recently certainly doesn't bother us. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Cardinal Health insiders selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we found 1 warning sign for Cardinal Health that deserve your attention before buying any shares. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching
Today we're going to take a look at the well-established HCA Healthcare, Inc. (NYSE:HCA). The company's stock saw a decent share price growth of 19% on the NYSE over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine HCA Healthcare's valuation and outlook in more detail to determine if there's still a bargain opportunity. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Good news, investors! HCA Healthcare is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that HCA Healthcare's ratio of 15.45x is below its peer average of 20.5x, which indicates the stock is trading at a lower price compared to the Healthcare industry. Although, there may be another chance to buy again in the future. This is because HCA Healthcare's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity. See our latest analysis for HCA Healthcare Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. HCA Healthcare's earnings over the next few years are expected to increase by 23%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since HCA is currently below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple. Are you a potential investor? If you've been keeping an eye on HCA for a while, now might be the time to make a leap. Its buoyant future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy HCA. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed assessment. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Our analysis shows 3 warning signs for HCA Healthcare (1 is a bit concerning!) and we strongly recommend you look at these before investing. If you are no longer interested in HCA Healthcare, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's at
Without the ability to feel pain, life is more dangerous. To avoid injury, pain tells us to use a hammer more gently, wait for the soup to cool or put on gloves in a snowball fight. Those with rare inherited disorders that leave them without the ability to feel pain are unable to protect themselves from environmental threats, leading to broken bones, damaged skin, infections and ultimately a shorter life span. In these contexts, pain is much more than a sensation: It is a protective call to action. But pain that is too intense or long-lasting can be debilitating. So how does modern medicine soften the call? As a neurobiologist and an anesthesiologist who study pain, this is a question we and other researchers have tried to answer. Science's understanding of how the body senses tissue damage and perceives it as pain has progressed tremendously over the past several years. It has become clear that there are multiple pathways that signal tissue damage to the brain and sound the pain alarm bell. Interestingly, while the brain uses different pain signaling pathways depending on the type of damage, there is also redundancy to these pathways. Even more intriguing, these neural pathways morph and amplify signals in the case of chronic pain and pain caused by conditions affecting nerves themselves, even though the protective function of pain is no longer needed. Painkillers work by tackling different parts of these pathways. Not every painkiller works for every type of pain, however. Because of the multitude and redundancy of pain pathways, a perfect painkiller is elusive. But in the meantime, understanding how existing painkillers work helps medical providers and patients use them for the best results. A bruise, sprain or broken bone from an injury all lead to tissue inflammation, an immune response that can lead to swelling and redness as the body tries to heal. Specialized nerve cells in the area of the injury called nociceptors sense the inflammatory chemicals the body produces and send pain signals to the brain. Common over-the-counter anti-inflammatory painkillers work by decreasing inflammation in the injured area. These are particularly useful for musculoskeletal injuries or other pain problems caused by inflammation such as arthritis. Nonsteroidal anti-inflammatories like ibuprofen (Advil, Motrin), naproxen (Aleve) and aspirin do this by blocking an enzyme called COX that plays a key role in a biochemical cascade that produces inflammatory chemicals. Blocking the cascade decreases the amount of inflammatory chemicals, and thereby reduces the pain signals sent to the brain. While acetaminophen (Tylenol), also known as paracetamol, doesn't reduce inflammation as NSAIDs do, it also inhibits COX enzymes and has similar pain-reducing effects. Prescription anti-inflammatory painkillers include other COX inhibitors, corticosteroids and, more recently, drugs that target and inactivate the inflammatory chemicals themselves. Because inflammatory chemicals are involved in other important physiological functions beyond just sounding the pain alarm, medications that block them will have side effects and potential health risks, including irritating the stomach lining and affecting kidney function. Over-the-counter medications are generally safe if the directions on the bottle are followed strictly. Corticosteroids like prednisone block the inflammatory cascade early on in the process, which is probably why they are so potent in reducing inflammation. However, because all the chemicals in the cascade are present in nearly every organ system, long-term use of steroids can pose many health risks that need to be discussed with a physician before starting a treatment plan. Many topical medications target nociceptors, the specialized nerves that detect tissue damage. Local anesthetics, like lidocaine, prevent these nerves from sending electrical signals to the brain. The protein sensors on the tips of other sensory neurons in the skin are also targets for topical painkillers. Activating these proteins can elicit particular sensations that can lessen the pain by reducing the activity of the damage-sensing nerves, like the cooling sensation of menthol or the burning sensation of capsaicin. Because these topical medications work on the tiny nerves in the skin, they are best used for pain directly affecting the skin. For example, a shingles infection can damage the nerves in the skin, causing them to become overactive and send persistent pain signals to the brain. Silencing those nerves with topical lidocaine or an overwhelming dose of capsaicin can reduce these pain signals. Nerve injuries, most commonly from arthritis and diabetes, can cause the pain-sensing part of the nervous system to become overactive. These injuries sound the pain alarm even in the absence of tissue damage. The best painkillers in these conditions are those that dampen that alarm. Antiepileptic drugs, such as gabapentin (Neurontin), suppress the pain-sensing system by blocking electrical signaling in the nerves. However, gabapentin can also reduce nerve activity in other parts of the nervous system, potentially leading to sleepiness and confusion. Antidepressants, such as duloxetine and nortriptyline, are thought to work by increasing certain neurotransmitters in the spinal cord and brain involved in regulating pain pathways. But they may also alter chemical signaling in the gastrointestinal tract, leading to an upset stomach. All these medications are prescribed by doctors. Opioids are chemicals found or derived from the opium poppy. One of the earliest opioids, morphine, was purified in the 1800s. Since then, medical use of opioids has expanded to include many natural and synthetic derivatives of morphine with varying potency and duration. Some common examples include codeine, tramadol, hydrocodone, oxycodone, buprenorphine and fentanyl. Opioids decrease pain by activating the body's endorphin system. Endorphins are a type of opioid your body naturally produces that decreases incoming signals of injury and produces feelings of euphoria – the so-called 'runner's high.' Opioids simulate the effects of endorphins by acting on similar targets in the body. Although opioids can decrease some types of acute pain, such as after surgery, musculoskeletal injuries like a broken leg or cancer pain, they are often ineffective for neuropathic injuries and chronic pain. Because the body uses opioid receptors in other organ systems like the gastrointestinal tract and the lungs, side effects and risks include constipation and potentially fatal suppression of breathing. Prolonged use of opioids may also lead to tolerance, where more drug is required to get the same painkilling effect. This is why opioids can be addictive and are not intended for long-term use. All opioids are controlled substances and are carefully prescribed by doctors because of these side effects and risks. Although cannabis has received a lot of attention for its potential medical uses, there isn't sufficient evidence available to conclude that it can effectively treat pain. Since the use of cannabis is illegal at the federal level in the U.S., high-quality clinical research funded by the federal government has been lacking. Researchers do know that the body naturally produces endocannabinoids, a form of the chemicals in cannabis, to decrease pain perception. Cannabinoids may also reduce inflammation. Given the lack of strong clinical evidence, physicians typically don't recommend them over FDA-approved medications. While sounding the pain alarm is important for survival, dampening the klaxon when it's too loud or unhelpful is sometimes necessary. No existing medication can perfectly treat pain. Matching specific types of pain to drugs that target specific pathways can improve pain relief, but even then, medications can fail to work even for people with the same condition. More research that deepens the medical field's understanding of the pain pathways and targets in the body can help lead to more effective treatments and improved pain management. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Rebecca Seal, University of Pittsburgh and Benedict Alter, University of Pittsburgh Read more: How do drugs know where to go in the body? A pharmaceutical scientist explains why some medications are swallowed while others are injected What is fentanyl and why is it behind the deadly surge in US drug overdoses? A medical toxicologist explains Sepsis is one of the most expensive medical conditions in the world – new research clarifies how it can lead to cell death Rebecca Seal receives funding from National Institutes of Health Benedict Alter receives funding from National Institutes of Health, Foundation for Anesthesia Education and Research, and the International Anesthesia Research Society.